Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Probability of Achieving Glycemic Control with Basal Insulin in Patients with Type 2 Diabetes in Real-World Practice in the USA

Probability of Achieving Glycemic Control with Basal Insulin in Patients with Type 2 Diabetes in... Diabetes Ther (2018) 9:1347–1358 https://doi.org/10.1007/s13300-018-0413-5 BRIEF REPORT Probability of Achieving Glycemic Control with Basal Insulin in Patients with Type 2 Diabetes in Real-World Practice in the USA . . . Lawrence Blonde Luigi Meneghini Xuejun Victor Peng . . . . Anders Boss Kyu Rhee Alka Shaunik Supriya Kumar . . Sidhartha Balodi Claire Brulle-Wohlhueter Rory J. McCrimmon Received: March 2, 2018 / Published online: March 29, 2018 The Author(s) 2018 least one valid glycated hemoglobin (HbA1c) ABSTRACT result recorded both within 90 days before and 720 days after BI initiation were selected. We Introduction: Basal insulin (BI) plays an estimated the changes from baseline in HbA1c important role in treating type 2 diabetes (T2D), every 6 months, the quarterly conditional especially when oral antidiabetic (OAD) medi- probabilities of reaching HbA1c \ 7% if a cations are insufficient for glycemic control. We patient had not achieved glycemic control prior conducted a retrospective, observational study to each quarter (Q), and the cumulative proba- using electronic medical records (EMR) data bility of reaching glycemic control over from the IBM Explorys database to evaluate 24 months. the probability of achieving glycemic control Results: Our cohort was representative of over 24 months after http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Diabetes Therapy Springer Journals

Probability of Achieving Glycemic Control with Basal Insulin in Patients with Type 2 Diabetes in Real-World Practice in the USA

Loading next page...
 
/lp/springer_journal/probability-of-achieving-glycemic-control-with-basal-insulin-in-sS0BKiEa3j
Publisher
Springer Journals
Copyright
Copyright © 2018 by The Author(s)
Subject
Medicine & Public Health; Internal Medicine; Diabetes; Cardiology; Endocrinology
ISSN
1869-6953
eISSN
1869-6961
DOI
10.1007/s13300-018-0413-5
Publisher site
See Article on Publisher Site

Abstract

Diabetes Ther (2018) 9:1347–1358 https://doi.org/10.1007/s13300-018-0413-5 BRIEF REPORT Probability of Achieving Glycemic Control with Basal Insulin in Patients with Type 2 Diabetes in Real-World Practice in the USA . . . Lawrence Blonde Luigi Meneghini Xuejun Victor Peng . . . . Anders Boss Kyu Rhee Alka Shaunik Supriya Kumar . . Sidhartha Balodi Claire Brulle-Wohlhueter Rory J. McCrimmon Received: March 2, 2018 / Published online: March 29, 2018 The Author(s) 2018 least one valid glycated hemoglobin (HbA1c) ABSTRACT result recorded both within 90 days before and 720 days after BI initiation were selected. We Introduction: Basal insulin (BI) plays an estimated the changes from baseline in HbA1c important role in treating type 2 diabetes (T2D), every 6 months, the quarterly conditional especially when oral antidiabetic (OAD) medi- probabilities of reaching HbA1c \ 7% if a cations are insufficient for glycemic control. We patient had not achieved glycemic control prior conducted a retrospective, observational study to each quarter (Q), and the cumulative proba- using electronic medical records (EMR) data bility of reaching glycemic control over from the IBM Explorys database to evaluate 24 months. the probability of achieving glycemic control Results: Our cohort was representative of over 24 months after

Journal

Diabetes TherapySpringer Journals

Published: Mar 29, 2018

References